+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Scar Treatment Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 160 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797993
The global scar treatment market value was USD 19.4 billion in 2022, driven by the prevalence of skin conditions, rising awareness about the availability of scar treatment options across the globe. The market size is anticipated to grow at a CAGR of 10.9% during the forecast period of 2023-2031 to achieve a value of USD 49.1 billion by 2031.

Scar Treatment: Introduction

Scar treatment refers to a variety of procedures and products aimed at reducing the appearance of scars resulting from surgery, injury, burns, acne, or other skin conditions. These treatments are designed to improve the appearance, texture, and pigmentation of scars, and may include topical products, minimally invasive procedures, or surgical interventions. The global scar treatment market comprises a wide range of products, such as creams, gels, silicone sheets, and laser devices, as well as services offered by dermatologists, plastic surgeons, and aesthetic clinics.

Scar Treatment Market Scenario

The global scar treatment market has experienced significant growth in recent years, driven by factors such as the increasing prevalence of skin conditions, rising awareness about the availability of scar treatment options, and advancements in scar treatment technologies. Furthermore, the growing demand for minimally invasive and non-invasive procedures, coupled with the expanding aesthetic industry, has contributed to the market's expansion.

North America: The largest market for scar treatment, driven by factors such as advanced healthcare infrastructure, a strong focus on research and development, and the presence of major scar treatment product manufacturers and service providers.

Europe: The second-largest market, with increasing demand for scar treatment due to growing awareness about the availability of advanced treatment options and a supportive regulatory framework.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of skin conditions, and growing investments in healthcare infrastructure.

Scar Treatment Market Segmentations

Market Breakup by Product Type

Topical Products

  • Creams
  • Gels
  • Silicon Sheets
  • Other Topical Products

Laser Products

  • CO2 Laser
  • Pulse-dyed Laser
  • Other Laser Products
  • Injectables
  • Others

Market Breakup by Scar Type

  • Atrophic Scars
  • Hypertrophic Scars
  • Contracture Scars
  • Stretch Marks
  • Others

Market Breakup by End User

  • Hospitals
  • Clinics
  • Homecare
  • Specialty Centers
  • Others

Market Breakup by Distribution Channels

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Scar Treatment Market

Some key trends of the market are as follows:
  • Growing demand for minimally invasive and non-invasive procedures: The increasing preference for minimally invasive and non-invasive scar treatment options, such as laser therapy, dermabrasion, and micro-needling, has driven market growth and innovation
  • Advancements in scar treatment technologies: Technological advancements in scar treatment products, such as silicone-based formulations and advanced laser devices, have improved the efficacy and safety of scar treatments, contributing to market expansion
  • Rising awareness about the availability of scar treatment options: Increasing awareness about the availability of various scar treatment options and their benefits has led to a greater demand for these treatments, particularly in emerging markets
Scar Treatment Market Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Smith Nephew
  • Merz Pharma
  • Lumenis
  • Perrigo Company plc
  • Mölnlycke Health Care AB
  • CCA Industries, Inc
  • Newmedical Technology Inc
  • Suneva Medical
  • Stratpharma AG
  • OLIX PHARMACEUTICALS, INC
  • Geomedics Pharma
  • Vicore Pharma
  • Nidus Pharma Pvt. Ltd
  • Sientra, Inc
  • RXi Pharmaceuticals
  • Johnson & Johnson Services, Inc
  • Novartis AG
  • Sanofi
  • Bausch Health
  • Bayer AG

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Scar Treatment Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Scar Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Scar Epidemiology (2016-2031)
5.3 Europe Scar Epidemiology (2016-2031)
5.4 Asia-Pacific Scar Epidemiology (2016-2031)
5.5 Latin America Scar Epidemiology (2016-2031)
5.6 Middle East & Africa Scar Epidemiology (2016-2031)
6 Global Scar Treatment Market Overview
6.1 Global Scar Treatment Market Historical Value (2016-2022)
6.2 Global Scar Treatment Market Forecast Value (2023-2031)
7 Global Scar Treatment Market Landscape
7.1 Global Scar Treatment Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Global Scar Treatment Product Landscape
7.2.1 Analysis by Product Type
7.2.2 Analysis by End User
7.2.3 Analysis by Distribution Channel
8 Scar Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Scar Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Scar Treatment Market Segmentation
11.1 Global Scar Treatment Market, by Product Type
11.1.1 Market Overview
11.1.2 Topical Products
11.1.2.1 Creams
11.1.2.2 Gels
11.1.2.3 Silicon Sheets
11.1.2.4 Other Topical Products
11.1.3 Laser Products
11.1.3.1 CO2 Laser
11.1.3.2 Pulse-dyed Laser
11.1.3.3 Other Laser Products
11.1.4 Injectables
11.1.5 Others
11.2 Global Scar Treatment Market, by Scar Type
11.2.1 Market Overview
11.2.2 Atrophic Scars
11.2.3 Hypertrophic Scars
11.2.4 Contracture Scars
11.2.5 Stretch Marks
11.2.6 Others
11.3 Global Scar Treatment Market, by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Clinics
11.3.4 Homecare
11.3.5 Specialty Centers
11.3.6 Others
11.4 Global Scar Treatment Market, by Distribution Channels
11.4.1 Market Overview
11.4.2 Hospitals Pharmacies
11.4.3 Retail Pharmacies
11.4.4 Online Pharmacies
11.4.5 Others
11.5 Global Scar Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Scar Treatment Therapy Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Scar Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Scar Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Scar Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Scar Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Patent Analysis
17.1 Analysis by Type of Patent
17.2 Analysis by Publication year
17.3 Analysis by Issuing Authority
17.4 Analysis by Patent Age
17.5 Analysis by CPC Analysis
17.6 Analysis by Patent Valuation
17.7 Analysis by Key Players
18 Grants Analysis
18.1 Analysis by year
18.2 Analysis by Amount Awarded
18.3 Analysis by Issuing Authority
18.4 Analysis by Grant Application
18.5 Analysis by Funding Institute
18.6 Analysis by NIH Departments
18.7 Analysis by Recipient Organization
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Funding Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Regulatory Framework
22.1 Regulatory Overview
22.1.1 US FDA
22.1.2 EU EMA
22.1.3 INDIA CDSCO
22.1.4 JAPAN PMDA
22.1.5 Others
23 Supplier Landscape
23.1 Smith Nephew
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Merz Pharma
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Lumenis
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Perrigo Company plc
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Mölnlycke Health Care AB
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 CCA Industries, Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Newmedical Technology Inc
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Suneva Medical
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Stratpharma AG
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 OLIX PHARMACEUTICALS, INC.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Geomedics Pharma
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Vicore Pharma
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Nidus Pharma Pvt. Ltd.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 Sientra, Inc.
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 RXi Pharmaceuticals
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
23.16 Johnson & Johnson Services, Inc.
23.16.1 Financial Analysis
23.16.2 Product Portfolio
23.16.3 Demographic Reach and Achievements
23.16.4 Mergers and Acquisitions
23.16.5 Certifications
23.17 Novartis AG
23.17.1 Financial Analysis
23.17.2 Product Portfolio
23.17.3 Demographic Reach and Achievements
23.17.4 Mergers and Acquisitions
23.17.5 Certifications
23.18 Sanofi
23.18.1 Financial Analysis
23.18.2 Product Portfolio
23.18.3 Demographic Reach and Achievements
23.18.4 Mergers and Acquisitions
23.18.5 Certifications
23.19 Bausch Health
23.19.1 Financial Analysis
23.19.2 Product Portfolio
23.19.3 Demographic Reach and Achievements
23.19.4 Mergers and Acquisitions
23.19.5 Certifications
23.20 Bayer AG
23.20.1 Financial Analysis
23.20.2 Product Portfolio
23.20.3 Demographic Reach and Achievements
23.20.4 Mergers and Acquisitions
23.20.5 Certifications
24 Global Scar Treatment Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Companies Mentioned

  • Smith Nephew
  • Merz Pharma
  • Lumenis
  • Perrigo Company plc
  • Mölnlycke Health Care Ab
  • Cca Industries, Inc.
  • Newmedical Technology Inc
  • Suneva Medical
  • Stratpharma AG
  • Olix Pharmaceuticals, Inc.
  • Geomedics Pharma
  • Vicore Pharma
  • Nidus Pharma Pvt. Ltd.
  • Sientra, Inc.
  • Rxi Pharmaceuticals
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Sanofi
  • Bausch Health
  • Bayer Ag

Methodology

Loading
LOADING...

Table Information